Anandamide uptake explained?

Trends in Pharmacological Sciences

Volumn 33, Issue 4, 2012, Pages 181-185

  Fowler, Christopher J ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CARRIER PROTEIN; ENDOCANNABINOID; FATTY ACID AMIDASE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORTER; SERINE DEHYDRATASE; SMALL INTERFERING RNA; VANILLOID RECEPTOR 1;

CALCIUM SIGNALING; DIFFUSION; ENDOCYTOSIS; ENZYME ACTIVITY; HUMAN; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINAL GANGLION; SYNAPTOSOME; TEMPERATURE DEPENDENCE;

ANIMALS; ARACHIDONIC ACIDS; CARRIER PROTEINS; CELL MEMBRANE; ENDOCANNABINOIDS; HUMANS; POLYUNSATURATED ALKAMIDES; PROTEIN TRANSPORT;

EID: 84859444756     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.01.001     Document Type: Review

References (62)

1. D. Centonze The endocannabinoid system in targeting inflammatory neurodegenerative diseases Trends Pharmacol. Sci. 28 2007 180 187
2. T. Biró The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities Trends Pharmacol. Sci. 30 2009 411 420
3. M.N. Hill The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants Trends Pharmacol. Sci. 30 2009 484 493
4. E. Keimpema Molecular model of cannabis sensitivity in developing neuronal circuits Trends Pharmacol. Sci. 32 2011 551 561
5. B.E. Alger, and J. Kim Supply and demand for endocannabinoids Trends Neurosci. 34 2011 304 315
6. K. Ahn Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders Expert Opin. Drug Discov. 4 2009 763 784
7. S. Oddi Evidence for the intracellular accumulation of anandamide in adiposomes Cell. Mol. Life Sci. 65 2008 840 850
8. M. Kaczocha Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2 J. Biol. Chem. 285 2010 2796 2806
9. V. Di Marzo Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 1994 686 691
10. D. Woodward Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin ethanolamides) in the feline iris Br. J. Pharmacol. 150 2007 342 352
11. N.T. Snider A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist Mol. Pharmacol. 75 2009 965 972
12. V. Di Marzo Anandamide: some like it hot Trends Pharmacol. Sci. 22 2001 346 349
13. C. Hillard Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion J. Neurochem. 69 1997 631 638
14. C. Hillard, and A. Jarrahian Cellular accumulation of anandamide: consensus and controversy Br. J. Pharmacol. 140 2003 802 808
15. M. Kaczocha Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase J. Biol. Chem. 281 2006 9066 9075
16. L. Thors, and C.J. Fowler Is there a temperature-dependent uptake of anandamide into cells? Br. J. Pharmacol. 149 2006 73 81
17. S. Glaser Evidence against the presence of an anandamide transporter Proc. Natl. Acad. Sci. U.S.A. 100 2003 4269 4274
18. A. Ligresti Further evidence for the existence of a specific process for the membrane transport of anandamide Biochem. J. 380 2004 265 272
19. N. Rimmerman Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line Br. J. Pharmacol. 153 2008 380 389
20. E. Di Pasquale The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependent PLoS ONE 4 2009 e4989
21. M. Bari Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis J. Biol. Chem. 280 2005 12212 12220
22. M. Bari Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells J. Neurosci. Res. 81 2005 275 283
23. Thors, L. and Fowler, C.J. (2007) The effect of methyl-ß- cyclodextrin treatment upon the viability and anandamide uptake capability of C6 glioma and P19 embryonic carcinoma cells. Focused Meeting on Cannabinoid Research, British Pharmacological Society. (http://www.pA2online.org/abstracts/ Vol5Issue1abst047P.pdf)
24. K.C. Calman In memory of William of Occam Lancet 354 1999 2172
25. T. Day Role of fatty acid amide hydrolase in the transport of the endogenous canabinoid anandamide Mol. Pharmacol. 59 2001 1369 1375
26. D. Deutsch The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase J. Biol. Chem. 276 2001 6967 6973
27. D. Fegley Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172 Proc. Natl. Acad. Sci. U.S.A. 101 2004 8756 8761
28. S. Ortega-Gutiérrez Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake Biochemistry 43 2004 8184 8190
29. J. Fu A catalytically silent FAAH-1 variant drives anandamide transport in neurons Nat. Neurosci. 15 2012 64 69
30. L. Thors Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake Br. J. Pharmacol. 152 2007 744 750
31. C. Hillard, and A. Jarrahian The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes Chem. Phys. Lipids 108 2000 123 134
32. M. Kaczocha Identification of intracellular carriers for the endocannabinoid anandamide Proc. Natl. Acad. Sci. U.S.A. 106 2009 6375 6380
33. S. Oddi Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins Chem. Biol. 16 2009 624 632
34. I. Bojesen, and H. Hansen Binding of anandamide to bovine serum albumin J. Lipid Res. 44 2003 1790 1794
35. M. Karlsson Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments Eur. J. Pharm. Sci. 22 2004 181 189
36. M. Beltramo Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1997 1094 1097
37. L. De Petrocellis Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity FEBS Lett. 483 2000 52 56
38. M.L. López-Rodríguez Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase J. Med. Chem. 46 2003 1512 1522
39. G. Ortar Novel selective and metabolically stable inhibitors of anandamide cellular uptake Biochem. Pharmacol. 65 2003 1473 1481
40. G. La Rana Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14- tetraenamide] J. Pharmacol. Exp. Ther. 317 2006 1365 1371
41. B. Costa AM404, an inhibitor of anandamide uptake, prevents pain behavior and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain Br. J. Pharmacol. 148 2006 1022 1032
42. S. Maione Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms Br. J. Pharmacol. 155 2008 775 782
43. C.J. Fowler Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis - a difficult issue to handle Eur. J. Pharmacol. 492 2004 1 11
44. C. Hillard Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase J. Mol. Neurosci. 33 2007 18 24
45. W. Lang Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase J. Med. Chem. 42 1999 896 902
46. S. Vandevoorde, and C.J. Fowler Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate Br. J. Pharmacol. 145 2005 885 893
47. E. Högestätt Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system J. Biol. Chem. 280 2005 31405 31412
48. A. Ligresti Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter PLoS ONE 5 2011 e10239
49. I. Bojesen, and H. Hansen Membrane transport of anandamide through resealed human red blood cell membranes J. Lipid Res. 46 2005 1652 1659
50. J. Ronesi Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport J. Neurosci. 24 2004 1673 1679
51. M. McFarland A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide J. Biol. Chem. 279 2004 41991 41997
52. M. McFarland RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells Mol. Pharmacol. 74 2008 101 108
53. L. Thors The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake Br. J. Pharmacol. 150 2007 951 960
54. M. Beltramo, and D. Piomelli Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol Neuroreport 11 2000 1231 1235
55. T. Bisogno The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors Eur. J. Biochem. 268 2001 1982 1989
56. C.J. Fowler, and N. Ghafouri Does the hydrolysis of 2- arachidonoylglycerol regulate its cellular uptake? Pharmacol. Res. 58 2008 72 76
57. D.L. Lynch, and P.H. Reggio Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer J. Comput. Aided Mol. Des. 20 2006 495 509
58. S. Oddi Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor J. Neurochem. 116 2011 858 865
59. N.B. Boneva Expression of fatty acid-binding proteins in adult hippocampal neurogenic niche of postischemic monkeys Hippocampus 21 2011 162 171
60. P. Racay Ischaemia-induced protein ubiquitinylation is differentially accompanied with heat-shock protein 70 expression after naïve and preconditioned ischaemia Cell. Mol. Neurobiol. 32 2012 107 119
61. M. Maccarrone Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility J. Immunol. 166 2001 7183 7189
62. K.C. Duggan (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Nat. Chem. Biol. 7 2011 803 809